Log In
Print
BCIQ
Print
Print this Print this
 

CX-4945

  Manage Alerts
Collapse Summary General Information
Company Senhwa Biosciences Inc.
DescriptionOral protein kinase CK2 inhibitor
Molecular Target Protein kinase CK2
Mechanism of ActionKinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationLiver cancer
Indication DetailsTreat advanced cholangiocarcinoma
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today